Biology & Ecology
Biology
Gram Statusunknown
Oxygen Tolerancemicroaerophile
Ecology
Primary Nichesgut
Reservoiranimal, human
Clinical Profile
Pathobiont
yes
no
context dependent
unknown
Clinical Rolescoloniser; opportunistic pathogen
Typical Specimenbiopsy; stool
Bloom Triggers
inflammation
Risk Contextsautoimmune hepatitis (AIH); genetic predisposition to autoimmunity; immunocompromised patients; impaired gut barrier function; systemic lupus erythematosus (SLE)
Clinical Associations:
E2
E3 — Strong human clinical evidence
E2 — Moderate human evidence
E1 — Limited / preliminary
E. gallinarum was detected by species-specific PCR and immunostaining in liver biopsies of 3/3 tested SLE patients and 5/6 tested AIH patients but in 0/6 healthy cadaveric liver donor controls; 16S rDNA sequencing showed Enterococcus spp. predominance in AIH and cirrhosis liver tissues relative to healthy controls (human case-control).
PMID:
29590047
E2
E3 — Strong human clinical evidence
E2 — Moderate human evidence
E1 — Limited / preliminary
Serum IgG antibody titers against E. gallinarum whole bacteria and its RNA were significantly elevated in the majority of SLE (n=15) and AIH (n=17) patients versus healthy controls (n=9); anti-E. gallinarum RNA IgG correlated with anti-human RNA autoantibody titers in SLE (R²=0.5132, p=0.0027) and AIH (R²=0.8245, p<0.0001) patients (human case-control).
PMID:
29590047
E2
E3 — Strong human clinical evidence
E2 — Moderate human evidence
E1 — Limited / preliminary
Monocolonization of germ-free C57BL/6 mice with E. gallinarum (n=4–10) induced gut barrier leakage, translocation to mesenteric veins, MLNs, and liver, and elevated anti-RNA IgG and anti-dsDNA IgG autoantibodies at 8 weeks (p<0.05 to p<0.001 vs. GF); neither E. faecalis nor B. thetaiotaomicron monocolonization induced autoantibodies under the same conditions.
PMID:
29590047
E2
E3 — Strong human clinical evidence
E2 — Moderate human evidence
E1 — Limited / preliminary
E. gallinarum monocolonization of GF C57BL/6 mice induced marked Th17 expansion in the small intestinal lamina propria (20.1% IL-17A+ vs. 0.50% GF, p<0.0001) and mesenteric lymph nodes (15.1% vs. 0.035%, p<0.001); Th17 expansion was absent in E. faecalis- and B. thetaiotaomicron-monocolonized mice (n=5 per group).
PMID:
29590047
E2
E3 — Strong human clinical evidence
E2 — Moderate human evidence
E1 — Limited / preliminary
E. gallinarum lysate or RNA co-cultured with autoimmune-prone (NZW×BXSB)F1 hepatocytes induced expression of autoantigens ERV gp70 (~15-fold) and β2-glycoprotein I (~3-fold), type I IFN-α (~30-fold), and the AhR/CYP1A1 pathway significantly above induction by E. faecalis or B. thetaiotaomicron (ANOVA, p<0.05 to p<0.0001, n=3 each); the same pattern was replicated in primary human hepatocytes.
PMID:
29590047
E2
E3 — Strong human clinical evidence
E2 — Moderate human evidence
E1 — Limited / preliminary
Administration of the AhR antagonist CH223191 to autoimmune-prone (NZW×BXSB)F1 mice gavaged with E. gallinarum significantly reduced serum anti-RNA IgG (p<0.001) and anti-dsDNA IgG (p<0.001) vs. untreated E. gallinarum-gavaged mice (n=4 per group), confirming that the AhR pathway mediates E. gallinarum-driven autoantibody induction.
PMID:
29590047
E2
E3 — Strong human clinical evidence
E2 — Moderate human evidence
E1 — Limited / preliminary
Oral vancomycin or ampicillin treatment of autoimmune-prone (NZW×BXSB)F1 mice (n=15 per group) prevented mortality, suppressed E. gallinarum translocation to mesenteric veins, MLNs, and liver, and eliminated anti-dsDNA IgG, anti-RNA IgG, anti-β2GPI IgG autoantibodies and Th17/Tfh cell expansion vs. untreated controls (p<0.05 to p<0.0001); neomycin was less effective and metronidazole had no significant effect on survival.
PMID:
29590047
E2
E3 — Strong human clinical evidence
E2 — Moderate human evidence
E1 — Limited / preliminary
Intramuscular vaccination with heat-killed E. gallinarum in autoimmune-prone (NZW×BXSB)F1 mice reduced serum autoantibody levels, prolonged survival, and prevented translocation to internal organs; vaccination against E. faecalis or B. thetaiotaomicron had no protective effect, indicating specificity of the E. gallinarum-driven autoimmune response.
PMID:
29590047
E1
E3 — Strong human clinical evidence
E2 — Moderate human evidence
E1 — Limited / preliminary
Enterococcus gallinarum undergoes within-host evolution into mucosally-adapted lineages that exhibit significantly increased translocation to the mesenteric lymph nodes and liver compared to luminal lineages in germ-free monocolonised mice.
PMID:
35831502
E1
E3 — Strong human clinical evidence
E2 — Moderate human evidence
E1 — Limited / preliminary
Enterococcus gallinarum mucosally-adapted liver isolates exhibit significantly increased resistance to lysozyme-mediated growth inhibition, cathelicidin-related antimicrobial peptide (mCRAMP) killing, and macrophage phagocytosis compared to luminal faecal isolates in vitro.
PMID:
35831502
D054884
Host-Pathogen Interactions
E1
E3 — Strong human clinical evidence
E2 — Moderate human evidence
E1 — Limited / preliminary
Enterococcus gallinarum liver-adapted isolates induce increased intestinal permeability and reduced epithelial barrier defences, including decreased mucus production, reduced intraepithelial lymphocyte recruitment, and altered tight junction protein expression, in germ-free monocolonised mice.
PMID:
35831502
D007413
Intestinal Mucosa
E1
E3 — Strong human clinical evidence
E2 — Moderate human evidence
E1 — Limited / preliminary
Enterococcus gallinarum liver-adapted isolates induce increased hepatic inflammatory gene expression, including upregulation of pro-inflammatory cytokines, interferon-stimulated genes, serum amyloid A proteins, and collagen, compared to faecal isolates in germ-free monocolonised mice.
PMID:
35831502
E1
E3 — Strong human clinical evidence
E2 — Moderate human evidence
E1 — Limited / preliminary
Enterococcus gallinarum translocation to the liver exacerbates lupus-like autoimmune manifestations including hepatosplenomegaly, proteinuria, and elevated anti-dsDNA autoantibodies in a TLR7 agonist (imiquimod)-induced autoimmunity mouse model.
PMID:
35831502
E1
E3 — Strong human clinical evidence
E2 — Moderate human evidence
E1 — Limited / preliminary
E1
E3 — Strong human clinical evidence
E2 — Moderate human evidence
E1 — Limited / preliminary
Enterococcus gallinarum has been detected in liver biopsies from patients with autoimmune hepatitis and primary sclerosing cholangitis, as reported in prior studies cited by the authors; this finding motivated the in vivo translocation experiments in this paper.
PMID:
35831502
Last reviewed: 2026-04-02
Evidence Timeline
Related Taxa
Shared Niche = same body site
Shared Risk = same vulnerable population
ⓘ